Mifamurtide (Adjuvant for High-Grade Osteosarcoma, non-US approval)
Treatment used for 1 condition
Total Trials
15
Total Participants
2K
Avg Effectiveness
55%
Avg Safety Score
60%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.